Company intelligence / Profile preview

Bio-Alai

Melbourne, Victoria, Australiabio-alai.com ↗

Ownership: Private
Development stage: Other

Overview

Bio-Alai offers an evidence-based personalized nutrition system designed to address chronic inflammation, ageing processes, and common chronic conditions. Its main products include the Bio-Alai Personalised Nutrition Program and My Alai Multisystem Support®, a TGA-listed complementary medicine. The system is based on over 20 years of clinical experience in nutritional medicine and has been used by hundreds of patients since its launch in 2023.

Therapeutic areas: ImmunologyGastroenterologyOther
Modalities: NutraceuticalPersonalized nutrition programComplementary medicine formulation (vitamins, minerals, polyphenols, antioxidants)
Industry: Food & Nutrition

Beyond the preview

Go deeper on Bio-Alai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Alai.

Explore the full profile